US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 87.250
  • -1.590-1.79%
Close Nov 4 16:00 ET
  • 87.500
  • +0.250+0.29%
Post 17:26 ET
4.19BMarket Cap-13259P/E (TTM)

Axsome Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.60%-30.11M
-818.52%-53.47M
-24.52%-145.08M
-10.15%-30.36M
-135.29%-53.55M
-65.04%-55.35M
82.17%-5.82M
-7.66%-116.51M
4.43%-27.56M
15.01%-22.76M
Net income from continuing operations
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.09%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.24%-61.24M
-28.50%-44.82M
Depreciation and amortization
18.00%1.99M
10.17%1.83M
55.25%6.83M
2.84%1.74M
3.75%1.74M
135.24%1.69M
432.69%1.66M
5,692.11%4.4M
319.10%1.69M
460.48%1.68M
Other non cash items
-59.95%2.98M
-177.33%-324K
1,000.44%53.1M
878.29%44.21M
156.22%1.03M
7,251.92%7.44M
5,137.50%419K
395.38%4.83M
332.72%4.52M
76,911.49%402K
Change In working capital
272.97%22.88M
29.29%-6.81M
-219.95%-28.39M
-79.49%3.43M
-183.10%-8.96M
-360.26%-13.23M
-925.24%-9.63M
7,205.56%23.67M
1,725.71%16.7M
418.26%10.79M
-Change in receivables
16.40%-18.91M
6.75%-6.62M
-51.52%-57.12M
5.70%-16.41M
-166.21%-11.01M
-39.89%-22.62M
---7.09M
---37.7M
---17.4M
---4.13M
-Change in inventory
150.19%528K
78.01%-972K
15.41%-4.46M
60.45%-1.8M
438.89%2.81M
-1,243.48%-1.05M
---4.42M
-87,816.67%-5.28M
-976,029.03%-4.54M
-14,859.35%-828K
-Change in prepaid assets
131.55%224K
-61.86%-3.92M
-95.06%-5.34M
-307.74%-1.32M
26.49%-888K
-181.33%-710K
-16.51%-2.42M
-2,755.34%-2.74M
-190.75%-323K
-3,601.25%-1.21M
-Change in payables and accrued expense
268.00%41.04M
9.03%4.7M
-44.47%38.53M
-41.11%22.94M
-99.26%125K
-9.55%11.15M
278.56%4.31M
30,463.44%69.38M
2,917.70%38.96M
726.26%16.96M
Cash from discontinued investing activities
Operating cash flow
45.60%-30.11M
-818.52%-53.47M
-24.52%-145.08M
-10.15%-30.36M
-135.29%-53.55M
-65.04%-55.35M
82.17%-5.82M
-7.66%-116.51M
4.43%-27.56M
15.01%-22.76M
Investing cash flow
Cash flow from continuing investing activities
60.90%-52K
-38.03%-98K
98.92%-582K
96.13%-7K
-462.12%-371K
99.75%-133K
66.82%-71K
-17,335.71%-53.7M
-40,033.04%-181K
74.49%-66K
Net PPE purchase and sale
60.90%-52K
-38.03%-98K
17.09%-582K
96.13%-7K
-462.12%-371K
44.81%-133K
66.82%-71K
-127.92%-702K
-40,033.04%-181K
74.49%-66K
Net business purchase and sale
----
----
--0
--0
----
----
----
---53M
--0
--0
Cash from discontinued investing activities
Investing cash flow
60.90%-52K
-38.03%-98K
98.92%-582K
96.13%-7K
-462.12%-371K
99.75%-133K
66.82%-71K
-17,335.71%-53.7M
-40,033.04%-181K
74.49%-66K
Financing cash flow
Cash flow from continuing financing activities
-94.16%14.38M
-102.30%-1.19M
16.32%331.01M
-100.19%-2K
-81.14%33.37M
226.09%246.08M
65.79%51.57M
2,456.89%284.58M
54.32%1.07M
40,236.64%176.95M
Net issuance payments of debt
-100.62%-186K
-100.30%-163K
88.89%85M
--0
--0
-33.33%30M
--55M
--45M
--0
--0
Net common stock issuance
----
----
6.15%258.75M
--0
-81.27%33.75M
----
----
3,178.15%243.76M
--0
--180.2M
Proceeds from stock option exercised by employees
2.60%6.74M
546.25%2.5M
98.67%12.42M
-59.53%1.15M
40.89%4.32M
3,632.95%6.57M
112.64%387K
42.00%6.25M
159.27%2.83M
598.45%3.06M
Net other financing activities
77.79%-3.44M
7.77%-3.53M
-141.14%-25.16M
34.94%-1.15M
25.65%-4.7M
-584.49%-15.49M
-4,194.38%-3.82M
-1,373.45%-10.43M
-182.54%-1.76M
---6.32M
Cash from discontinued financing activities
Financing cash flow
-94.16%14.38M
-102.30%-1.19M
16.32%331.01M
-100.19%-2K
-81.14%33.37M
226.09%246.08M
65.79%51.57M
2,456.89%284.58M
54.32%1.07M
40,236.64%176.95M
Net cash flow
Beginning cash position
34.45%331.44M
92.29%386.19M
132.26%200.84M
83.09%416.56M
495.57%437.11M
191.02%246.52M
132.26%200.84M
-52.97%86.47M
98.49%227.52M
-48.03%73.39M
Current changes in cash
-108.28%-15.78M
-219.88%-54.75M
62.06%185.35M
-13.84%-30.37M
-113.33%-20.55M
1,784.62%190.6M
2,687.71%45.67M
217.42%114.37M
5.23%-26.68M
679.50%154.13M
End cash Position
-27.79%315.66M
34.45%331.44M
92.29%386.19M
92.29%386.19M
83.09%416.56M
495.57%437.11M
191.02%246.52M
132.26%200.84M
132.26%200.84M
98.49%227.52M
Free cash flow
45.64%-30.16M
-809.11%-53.57M
-24.27%-145.66M
-9.46%-30.37M
-136.24%-53.92M
-64.25%-55.48M
82.07%-5.89M
-8.00%-117.21M
3.80%-27.74M
15.58%-22.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.60%-30.11M-818.52%-53.47M-24.52%-145.08M-10.15%-30.36M-135.29%-53.55M-65.04%-55.35M82.17%-5.82M-7.66%-116.51M4.43%-27.56M15.01%-22.76M
Net income from continuing operations -18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.09%-67.17M71.69%-11.22M-43.50%-187.13M-80.24%-61.24M-28.50%-44.82M
Depreciation and amortization 18.00%1.99M10.17%1.83M55.25%6.83M2.84%1.74M3.75%1.74M135.24%1.69M432.69%1.66M5,692.11%4.4M319.10%1.69M460.48%1.68M
Other non cash items -59.95%2.98M-177.33%-324K1,000.44%53.1M878.29%44.21M156.22%1.03M7,251.92%7.44M5,137.50%419K395.38%4.83M332.72%4.52M76,911.49%402K
Change In working capital 272.97%22.88M29.29%-6.81M-219.95%-28.39M-79.49%3.43M-183.10%-8.96M-360.26%-13.23M-925.24%-9.63M7,205.56%23.67M1,725.71%16.7M418.26%10.79M
-Change in receivables 16.40%-18.91M6.75%-6.62M-51.52%-57.12M5.70%-16.41M-166.21%-11.01M-39.89%-22.62M---7.09M---37.7M---17.4M---4.13M
-Change in inventory 150.19%528K78.01%-972K15.41%-4.46M60.45%-1.8M438.89%2.81M-1,243.48%-1.05M---4.42M-87,816.67%-5.28M-976,029.03%-4.54M-14,859.35%-828K
-Change in prepaid assets 131.55%224K-61.86%-3.92M-95.06%-5.34M-307.74%-1.32M26.49%-888K-181.33%-710K-16.51%-2.42M-2,755.34%-2.74M-190.75%-323K-3,601.25%-1.21M
-Change in payables and accrued expense 268.00%41.04M9.03%4.7M-44.47%38.53M-41.11%22.94M-99.26%125K-9.55%11.15M278.56%4.31M30,463.44%69.38M2,917.70%38.96M726.26%16.96M
Cash from discontinued investing activities
Operating cash flow 45.60%-30.11M-818.52%-53.47M-24.52%-145.08M-10.15%-30.36M-135.29%-53.55M-65.04%-55.35M82.17%-5.82M-7.66%-116.51M4.43%-27.56M15.01%-22.76M
Investing cash flow
Cash flow from continuing investing activities 60.90%-52K-38.03%-98K98.92%-582K96.13%-7K-462.12%-371K99.75%-133K66.82%-71K-17,335.71%-53.7M-40,033.04%-181K74.49%-66K
Net PPE purchase and sale 60.90%-52K-38.03%-98K17.09%-582K96.13%-7K-462.12%-371K44.81%-133K66.82%-71K-127.92%-702K-40,033.04%-181K74.49%-66K
Net business purchase and sale ----------0--0---------------53M--0--0
Cash from discontinued investing activities
Investing cash flow 60.90%-52K-38.03%-98K98.92%-582K96.13%-7K-462.12%-371K99.75%-133K66.82%-71K-17,335.71%-53.7M-40,033.04%-181K74.49%-66K
Financing cash flow
Cash flow from continuing financing activities -94.16%14.38M-102.30%-1.19M16.32%331.01M-100.19%-2K-81.14%33.37M226.09%246.08M65.79%51.57M2,456.89%284.58M54.32%1.07M40,236.64%176.95M
Net issuance payments of debt -100.62%-186K-100.30%-163K88.89%85M--0--0-33.33%30M--55M--45M--0--0
Net common stock issuance --------6.15%258.75M--0-81.27%33.75M--------3,178.15%243.76M--0--180.2M
Proceeds from stock option exercised by employees 2.60%6.74M546.25%2.5M98.67%12.42M-59.53%1.15M40.89%4.32M3,632.95%6.57M112.64%387K42.00%6.25M159.27%2.83M598.45%3.06M
Net other financing activities 77.79%-3.44M7.77%-3.53M-141.14%-25.16M34.94%-1.15M25.65%-4.7M-584.49%-15.49M-4,194.38%-3.82M-1,373.45%-10.43M-182.54%-1.76M---6.32M
Cash from discontinued financing activities
Financing cash flow -94.16%14.38M-102.30%-1.19M16.32%331.01M-100.19%-2K-81.14%33.37M226.09%246.08M65.79%51.57M2,456.89%284.58M54.32%1.07M40,236.64%176.95M
Net cash flow
Beginning cash position 34.45%331.44M92.29%386.19M132.26%200.84M83.09%416.56M495.57%437.11M191.02%246.52M132.26%200.84M-52.97%86.47M98.49%227.52M-48.03%73.39M
Current changes in cash -108.28%-15.78M-219.88%-54.75M62.06%185.35M-13.84%-30.37M-113.33%-20.55M1,784.62%190.6M2,687.71%45.67M217.42%114.37M5.23%-26.68M679.50%154.13M
End cash Position -27.79%315.66M34.45%331.44M92.29%386.19M92.29%386.19M83.09%416.56M495.57%437.11M191.02%246.52M132.26%200.84M132.26%200.84M98.49%227.52M
Free cash flow 45.64%-30.16M-809.11%-53.57M-24.27%-145.66M-9.46%-30.37M-136.24%-53.92M-64.25%-55.48M82.07%-5.89M-8.00%-117.21M3.80%-27.74M15.58%-22.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data